- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04704284
Comparing MRI to CT on Pediatric Craniosynostosis.
May 16, 2023 updated by: Julie B. Guerin, Mayo Clinic
Comparative Analysis of Zero Echo-time MRI and CT for Pediatric Craniosynostosis
The purpose of this study is to develop and test the effectiveness and diagnostic quality of Zero Echo Time Magnetic Resonance Imaging (ZTE MRI) in comparison to CT.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic in Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Pediatric patients 0-18 of age will be recruited by our surgical colleagues based on the clinical concern for craniosynostosis and possible need for calvarial reconstruction.
Exclusion Criteria:
- Lack of consent
- Contraindication/inability to undergo both examinations within the designated time period and/or undiagnostic image quality.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ZTE MRI Imaging
Pediatric patients that have gotten a clinically indicated CT within a 6 week time period will receive a Zero Echo Time Magnetic Resonance Imaging (ZTE MRI)
|
Magnetic Resonance Imaging (MRI) with zero echo-time (ZTE) that uses proton density differences rather than T2 relaxation time differences to achieve contrast.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Concordance between ZTE and CT imaging diagnosis
Time Frame: 2 years
|
90% or greater concordance between ZTE and CT findings, established by evaluating at least 37 patients over the course of two years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Julie B Guerin, MD, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 14, 2020
Primary Completion (Anticipated)
April 1, 2024
Study Completion (Anticipated)
April 1, 2024
Study Registration Dates
First Submitted
December 8, 2020
First Submitted That Met QC Criteria
January 8, 2021
First Posted (Actual)
January 11, 2021
Study Record Updates
Last Update Posted (Actual)
May 17, 2023
Last Update Submitted That Met QC Criteria
May 16, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-007373
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Craniosynostosis
-
University of Missouri-ColumbiaZimmer BiometWithdrawnMetopic CraniosynostosisUnited States
-
National Human Genome Research Institute (NHGRI)CompletedCraniosynostosis | Philadelphia Type CraniosynostosisUnited States
-
Yonsei UniversityCompletedCraniosynostosis Patients Undergoing Distraction OsteotomyKorea, Republic of
-
Baylor College of MedicineRecruitingCraniosynostosis, SagittalUnited States
-
Acıbadem Atunizade HospitalCompletedDevelopmental Delay | Craniosynostosis, Sagittal | ScaphocephalyTurkey
-
Tel-Aviv Sourasky Medical CenterUnknownCraniosynostosis Repair | Untethering of Cord
-
University Hospital, MontpellierRecruiting
-
Children's National Research InstituteActive, not recruiting
-
Boston Children's HospitalCompletedCraniosynostosisUnited States
-
Assistance Publique - Hôpitaux de ParisUniversité de Cergy PontoiseCompleted
Clinical Trials on Zero Echo Time Magnetic Resonance Imaging (ZTE MRI)
-
University Hospital, BordeauxUnknown
-
GE HealthcareCompleted
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; American Heart AssociationRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingProstate CarcinomaUnited States
-
Norwegian University of Science and TechnologySt. Olavs HospitalRecruitingHeart Diseases | Schizophrenia | Heart; Functional DisturbanceNorway
-
University of MichiganPhilips Healthcare; General ElectricCompleted
-
American College of RadiologyPennsylvania Department of HealthCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingBrain NeoplasmUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingProstate Adenocarcinoma | Prostate CarcinomaUnited States